Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?
Tamera Jo
TJ
Corte
Nicole S
NS
Goh
Ian N
IN
Glaspole
Christopher J
CJ
Zappala
Peter M
PM
Hopkins
Margaret L
ML
Wilsher
D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000401:mortality* / Q000628:therapy*